Michael H. Goldstien, M.D. Net Worth & Insider Trades

Michael H. Goldstien, M.D. - Chief Medical Officer, Ocular Therapeutix, Inc

As of May 30, 2019

What is Michael H. Goldstien, M.D.'s Net Worth?

The current estimated net worth of Ocular Therapeutix, Inc's Chief Medical Officer, Michael H. Goldstien, M.D., is estimated to be about $97.09K . Michael H. Goldstien, M.D. owns about 25,686 units of Ocular Therapeutix, Inc common stock. Recently at Ocular Therapeutix, Inc, Michael H. Goldstien, M.D. has sold an estimated value of $0 worth.

What is Michael H. Goldstien, M.D.'s Past Insider Trading?

Michael H. Goldstien, M.D.'s largest purchase order was 12,000 units , worth over $30.12K on May 30, 2019. In total, Michael H. Goldstien, M.D. has made about 1 transaction recently at Ocular Therapeutix, Inc. Michael H. Goldstien, M.D. usually trades in May, with the busiest year in 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Michael H. Goldstien, M.D.'s Salary in 2020?

As Chief Medical Officer of Ocular Therapeutix, Inc, Michael H. Goldstien, M.D. has a total base salary of $440,000 . Michael H. Goldstien, M.D. received compensation valued at about $1,336,250 in 2020 after becoming Chief Medical Officer.

What is Michael H. Goldstien, M.D.'s' Mailing Address?

  • Mailing address is C/o Agtc 14193 NW 119th Terrace, Suite #10 Alachua FL 32615 FL

Ocular Therapeutix, Inc Executive Compensation

Name
Year
Salary
Total
Antony Mattessich 2020 $600,000 $2,163,150
Antony Mattessich 2019 $581,796 $2,126,146
Michael Goldstein, M.D. 2020 $440,000 $1,336,250
Michael Goldstein, M.D. 2019 $423,906 $1,007,731
Philip C. Strassburger, Esq. 2020 $125,592 $2,413,764
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1393434/000155837021005257/tmb-20210618xdef14a.htm

What are Ocular Therapeutix, Inc's Past Insider Trades?

Ocular Therapeutix, Inc's most recent insider trade came on May 16, 2022 by Jeffrey S Heier who bought 15,000 units worth $45.75K . In the last 8 years, insiders at Ocular Therapeutix, Inc have sold an estimated value of $72.54M and bought an estimated value of $26.53M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Amarpreet Sawhney, Chairman the Board,  Charles M Warden, Director,  and Richard L. Lindstrom, M.D., Director .

OCULAR THERAPEUTIX, INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1